Clinical Trials Logo

Clinical Trial Summary

Slowing of kidney function occurs in a minority of people given dye during angiography. The purpose of this study is to compare two different types of fluid given into a vein to reduce the risk of kidney injury: salt in water or baking soda in water.


Clinical Trial Description

A decline in kidney function after contrast is associated with prolonged hospital stay, adverse cardiac events, and higher mortality both in hospital and in the long term. Deliberate administration of fluids is recommended to reduce the risk of contrast nephropathy. However, data to support specific recommendations are lacking and the optimal fluid regimen remains unclear.

It has been hypothesized that alkalinization of tubular fluid might be beneficial by reducing pH dependent free radical levels. A recent trial found a lower frequency of creatinine rise > 25% within two days of contrast with a 7 hour infusion of isotonic sodium bicarbonate than with saline infusion (Merten GJ, JAMA 2004). However, it remains to be proven that bicarbonate is superior as this trial has a number of methodological flaws.

Comparison: IV 1/6 M sodium bicarbonate OR IV 0.9% saline, each isotonic fluid given at the same rate of sodium administration (3.25 ml/Kg over 1 hour pre-contrast, followed by 1.1 ml/Kg/hr for 6 hours for bicarbonate; 3.5 ml/Kg over 1 hour pre-contrast, followed by 1.2 ml/Kg/hr for 6 hours for saline). Total infusion time 7 hours (for both). Maximum rate of fluid permitted is that for a body weight of 110 Kg. Intra-vascular iso- or low-osmolality contrast in the minimal dose needed to complete the required imaging. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00384995
Study type Interventional
Source Italian Society of Nephrology
Contact
Status Terminated
Phase Phase 4
Start date December 2006
Completion date July 2009

See also
  Status Clinical Trial Phase
Completed NCT00982527 - Fenoldopam in Pediatric Cardiac Surgery Phase 3
Completed NCT00908843 - Prevention of Contrast Induced Nephropathy (NIC) by Intravenous Versus Oral Rehydration N/A
Completed NCT00654992 - Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery Phase 2/Phase 3
Completed NCT05407272 - Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative Care N/A
Not yet recruiting NCT05399420 - Study of Kidney Circulating Cell-free DNA in Patients With Acute Kidney Failure
Recruiting NCT04334707 - Kidney Precision Medicine Project
Completed NCT04072432 - A Study of RBT-3 in Healthy Volunteers and Volunteers With Stage 3-4 Chronic Kidney Disease Phase 1
Recruiting NCT00230412 - Study of Heat Shock Proteins as Prognostic Factor of Acute Renal Failure in Children (HSP-Study) N/A
Completed NCT00148044 - Uremic Toxins of Patients With Acute Kidney Failure N/A
Active, not recruiting NCT04450095 - Effects of Endothelin Receptor Antagonist on Ischemic Kidney Injury During Nephron Sparing Surgery Phase 2
Terminated NCT05747053 - Personalization of Immunosuppressive Treatment for Organ Transplant Recipients
Completed NCT03353389 - Review of Trend in Incidence and Characteristics of Hospital-acquired Acute Kidney Injury in Hospital Selayang
Completed NCT03727581 - Ultrasound for Guidewire Detection
Completed NCT00912184 - Study Comparing High Cut-off Haemofiltration With Standard Haemofiltration in Acute Renal Failure Phase 1/Phase 2
Recruiting NCT00522756 - Preventing Acute Renal Failure After Cardiac Surgery in High Risk Patients Using Sodium Bicarbonate Therapy Phase 3
Completed NCT00484354 - Use of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery Phase 2
Terminated NCT00316576 - Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA) N/A
Completed NCT00122018 - An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery Phase 2
Unknown status NCT01359722 - N-acetylcysteine to Prevent Renal Failure N/A
Completed NCT00286273 - Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration Phase 4